Evidence map›Paper›PMID 36424971›Full record

ArticleFrontiers in public health2022

Real-time mortality statistics during the COVID-19 pandemic: A proposal based on Spanish data, January-March, 2021.

Juan Equiza-Goñi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Juan Equiza-GoñiFacultad de Ciencias Económicas y Empresariales, Universidad de Navarra, Pamplona, España.
Universidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: During the COVID-19 pandemic, surveillance systems worldwide underestimated mortality in real time due to longer death reporting lags. In Spain, the mortality monitor "MoMo" published downward biased excess mortality estimates daily. I study the correction of such bias using polynomial regressions in data from January to March 2021 for Spain and the Comunitat Valenciana, the region with the highest excess mortality. Methods: This adjustment for real-time statistics consisted of (1) estimating forthcoming revisions with polynomial regressions of past revisions, and (2) multiplying the daily-published excess mortality by these estimated revisions. The accuracy of the corrected estimates compared to the original was measured by contrasting their mean absolute errors (MAE) and root mean square errors (RMSE). Results: Applying quadratic and cubic regressions improved the first communication of cumulative mortality in Spain by 2-3%, on average, and the flow in registered deaths by 20%. However, for the Comunitat Valenciana, those corrections improved the first publications of the cumulative mortality by 36-45%, on average; their second publication, by 23-30%; and the third, by 15-21%. The flow of deaths registered each day improved by 62-63% on their first publication, by 19-36% on the second, and by 12-17% on the third. Conclusion: It is recommended that MoMo's estimates for excess mortality be corrected from the effect of death reporting lags by using polynomial regressions. This holds for the flows in each date and their cumulative sum, as well as national and regional data. These adjustments can be applied by surveillance systems in other countries.

Indexed as

COVID-19Influenza, HumanCommunicationHumansPandemicsSpainCOVID-19health communicationmortalitynowcastingpublic health surveillance

Identifiers

PMID36424971
PMCPMC9679298
OpenAlexW4308595053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.